John Overdeck’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

John Overdeck’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-155,169	Closed	-$17.5M	–	3418
2015 Q4	$17.5M	Sell	155,169 -105,614	-40%	-$11.6M	0.08%	270
2015 Q3	$30.7M	Sell	260,783 -19,238	-7%	-$2.51M	0.16%	169
2015 Q2	$21.7M	Buy	280,021 +91,245	+48%	+$5.98M	0.1%	246
2015 Q1	$10.9M	Buy	188,776 +100,058	+113%	+$4.25M	0.05%	443
2014 Q4	$2.86M	Buy	+88,718	New	+$2.66M	0.02%	871
2014 Q2	–	Sell	-39,075	Closed	-$781K	–	2589
2014 Q1	$781K	Buy	+39,075	New	+$758K	﹤0.01%	1308
2013 Q4	–	Sell	-10,065	Closed	-$107K	–	2600
2013 Q3	$107K	Buy	+10,065	New	+$88K	﹤0.01%	1739

Other funds holding ANAC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

John Overdeck's ANAC Position: Q1 2016 in Review

John Overdeck sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2016, closing a stake of 155,169 shares — an estimated $17.5M sold.

John Overdeck first reported a position in ANAC in Q3 2013 and held it in 7 quarters. The position peaked at $30.7M in Q3 2015. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

John Overdeck reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
John Overdeck sold 155,169 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $17.5M.
John Overdeck first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 7 quarters.
John Overdeck's ANACOR PHARMACEUTICALS INC COM position peaked at $30.7M in Q3 2015.
199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on Two Sigma Investments's 13F filing for Q1 2016, filed 16 May 2016.